Research ArticleArticle
Open Access
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C. Genovese, Elizabeth Hsia, Stanley M. Belkowski, Caly Chien, Tara Masterson, Robin L. Thurmond, Carl L. Manthey, Xiaoyu (David) Yan, Tingting Ge, Carol Franks and Andrew Greenspan
The Journal of Rheumatology October 2015, 42 (10) 1752-1760; DOI: https://doi.org/10.3899/jrheum.141580
Mark C. Genovese
From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey,
USA.
Elizabeth Hsia
Stanley M. Belkowski
Caly Chien
Tara Masterson
Robin L. Thurmond
Carl L. Manthey
Xiaoyu (David) Yan
Tingting Ge
Carol Franks
Andrew Greenspan
REFERENCES
- 1.↵
- 2.↵
- Singh JA,
- Furst DE,
- Bharat A,
- Curtis JR,
- Kavanaugh AF,
- Kremer JM,
- et al.
- 3.↵
- 4.↵
- Burmester GR,
- Blanco R,
- Charles-Schoeman C,
- Wollenhaupt J,
- Zerbini C,
- Benda B,
- et al;
- ORAL Step investigators
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Prevoo ML,
- van ‘t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 12.↵
- Wells G,
- Becker JC,
- Teng J,
- Dougados M,
- Schiff M,
- Smolen J,
- et al.
- 13.↵
- Kolodziejczyk K,
- Stappers AE,
- Teleha CA,
- Weerts KJH
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- Korkosz M,
- Bukowska-Strakova K,
- Sadis S,
- Grodzicki T,
- Siedlar M
- 18.↵
- Kremer JM,
- Cohen S,
- Wilkinson BE,
- Connell CA,
- French JL,
- Gomez-Reino J,
- et al.
- 19.↵
- Rahman MU,
- Buchanan J,
- Doyle MK,
- Hsia EC,
- Gathany T,
- Parasuraman S,
- et al.
- 20.↵
- de Hair MJ,
- Harty LC,
- Gerlag DM,
- Pitzalis C,
- Veale DJ,
- Tak PP
- 21.↵
- Burmester GR,
- Weinblatt ME,
- McInnes IB,
- Porter D,
- Barbarash O,
- Vatutin M,
- et al.
- 22.↵
- 23.↵
- 24.↵
- Lacey DC,
- Achuthan A,
- Fleetwood AJ,
- Dinh H,
- Roiniotis J,
- Scholz GM,
- et al.
- 25.↵
- Iwata Y,
- Boström EA,
- Menke J,
- Rabacal WA,
- Morel L,
- Wada T,
- et al.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 10
1 Oct 2015
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C. Genovese, Elizabeth Hsia, Stanley M. Belkowski, Caly Chien, Tara Masterson, Robin L. Thurmond, Carl L. Manthey, Xiaoyu (David) Yan, Tingting Ge, Carol Franks, Andrew Greenspan
The Journal of Rheumatology Oct 2015, 42 (10) 1752-1760; DOI: 10.3899/jrheum.141580
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C. Genovese, Elizabeth Hsia, Stanley M. Belkowski, Caly Chien, Tara Masterson, Robin L. Thurmond, Carl L. Manthey, Xiaoyu (David) Yan, Tingting Ge, Carol Franks, Andrew Greenspan
The Journal of Rheumatology Oct 2015, 42 (10) 1752-1760; DOI: 10.3899/jrheum.141580